Navigation Links
Spectral to bring anti-sepsis therapy to the U.S. market
Date:9/23/2008

TORONTO, Sept. 23 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX: SDI) today announced that it has agreed to key terms with Toray Industries Inc. of Japan to obtain the exclusive development and commercial rights in the U.S. for Toraymyxin(TM), a therapeutic for the treatment of sepsis that removes endotoxin from the bloodstream. Under the terms of the agreement, the Company will seek FDA approval for a combined product for the treatment of severe sepsis that will include Toraymyxin(TM) and Spectral's Endotoxin Activity Assay (EAA(TM)), the only FDA cleared diagnostic for the measurement of endotoxin. The conclusion of final commercial agreements is subject only to the completion of due diligence by Spectral and the determination of an approved clinical development pathway with the U.S. FDA.

"Toraymyxin(TM) is marketed in Japan and Europe and has been used to treat more than 50,000 sepsis patients safely and effectively. Spectral's EAA (TM) can identify patients that will benefit from Toraymyxin(TM) and monitor the effects of the treatment," said Dr. Paul Walker, President and CEO of Spectral. "This combination of the EAA(TM) diagnostic and the Toraymyxin(TM) therapeutic has been utilized by clinicians in Europe since November 2007 and has demonstrated the potential to lead to a significant reduction in mortality, as documented in the findings presented at the 28th International Symposium on Intensive Care and Emergency Medicine in March 2008. We believe that this combined treatment can fulfill a major unmet need for the approximately 100,000 patients that develop severe sepsis or septic shock in the U.S. each year."

"The business alliance with Toray and the specific combination of our approved diagnostic with their therapeutic device represent a significant market opportunity for Spectral," said Anthony Businskas, Spectral's Executive Vice-President and CFO. "Over the coming months, we expect to complete our due diligence and discuss t
'/>"/>

SOURCE Spectral Diagnostics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay
2. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
3. Spectral announces presentation of data on improving sepsis patient management with EAA(TM) and Toraymyxin(TM) combination
4. Spectral and Toray expand collaboration to include new geographic territories
5. Spectrals EAA(TM) to be used in Phase III study for a sepsis anti-endotoxin therapy
6. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
7. Spectral announces 2007 financial results
8. Spectral appoints Anthony Bihl to Board of Directors
9. Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
10. CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy
11. US Patent and Trademark Office Allows CRis Patent Application for Spectral Imaging of Deep Tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Gene synthesis and bioengineering company ... into a technology access and services agreement with ... proprietary protein engineering technology, known as “ProteinGPS®” to ... extremely excited that the global leader ADM has ... bioengineering technology has now been validated through many ...
(Date:12/17/2014)... , Dec. 17, 2014 Tigercat Pharma, ... 2 study evaluating the investigational oral NK-1 receptor ... with severe, chronic itch who are unresponsive or ... including topical steroids and antihistamines. ... Visual Analog Scale (VAS) itch score from baseline, ...
(Date:12/15/2014)... 2014  GlassesOff Inc. (OTCBB: GLSO) announced today the ... independent director of the Company,s Board of Directors. ... as its CEO until its acquisition by Stanley ... transaction. Recognized as the inventor of the first Wi-Fi-based ... Wi-Fi -based RFID solutions focused on improving operational efficiency, ...
(Date:12/13/2014)... Clarassance, a privately held clinical-stage biotechnology company ... Therabron Therapeutics , Inc. The new name is derived ... structure in the lungs similar to branches on a ... protein therapeutics for the treatment of respiratory diseases. ... name to mark the company's escalation into the clinical ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... Wis . - Logistics Health, Inc ., a ... has established a Web-based optimization tool to help client ... announcement, which came at the American Occupational Health ... would launch Health & Productivity Management Optimization, according to ...
... Expo for Municipal Broadband as a guest of the Graham ... with several awards for innovation and achievement in municipal government. ... a rebirth of the American municipality. , , The need ... infrastructure. , , The need to bring new business concepts ...
... Madison, Wis . - A Madison company that is ... effects of chemotherapy and radiotherapy has closed on a ... Investors of Madison. , , ProCertus BioPharm , ... begin clinical studies with cancer patients to demonstrate proof-of-concept ...
Cached Biology Technology:New Urbanism: Community planning Feng Shui 2New Urbanism: Community planning Feng Shui 3New Urbanism: Community planning Feng Shui 4New Urbanism: Community planning Feng Shui 5New Urbanism: Community planning Feng Shui 6ProCertus BioPharm secures $2.3M in financing 2ProCertus BioPharm secures $2.3M in financing 3
(Date:12/17/2014)... , Dec. 16, 2014 Research and ... the addition of the "Global Chemical Sensor ... http://photos.prnewswire.com/prnh/20130307/600769 ... the increasing demand for medical sensors in biomedical ... data for quick and correct diagnosis during surgical ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... to their offering. One major ... of multimodal biometric systems. Multimodal biometric systems utilize ... verification and identification purposes. This helps to reduce ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader in ... seeing a staggering demand from its licensees for highly ... revealed, is not solely coming from fitness and health ... "A wearable is only as useful as ... is the ultimate driver in long-term mass consumer adoption ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... Conn., May 22, 2012 /PRNewswire-iReach/ -- Global ... bird discounted registration for three significant international healthcare conferences: ... – Latin America October 29-30, ... Annual World Health Care Congress – Latin America ...
... Antibodies that help to stop the HIV virus have ... Center isolated the antibodies from immune cells called B cells ... showed that the B cells in breast milk can generate ... HIV-1 can be transmitted from mother to child via ...
... Researchers at the Hebrew University of Jerusalem have ... cells from stem cells of Fragile X patients. The ... restoration of normal gene expression in Fragile X patients. ... of inherited mental retardation, affecting hundreds of thousands of ...
Cached Biology News:Early Bird Discounts Available on International Healthcare and Biotechnology Conferences, Save Up To $600 with Global Information 2Early Bird Discounts Available on International Healthcare and Biotechnology Conferences, Save Up To $600 with Global Information 3Newly discovered breast milk antibodies help neutralize HIV 2Newly discovered breast milk antibodies help neutralize HIV 3Stem cell research paves way for progress on dealing with Fragile X retardation 2
... Storage Racks for Standard 3" Boxes. ... all makes and models of upright ... high quality stainless steel and can ... steel or plastic boxes. Custom ...
... assays utilize the membrane-permeant ester forms ... charged fluorescent beta-lactamase substrates, CCF2 and ... the cell, where cleavage by endogeneous ... their negatively charged forms, thereby trapping ...
... The ISOQUANT(R) Isoaspartate Detection Kit is ... residues in proteins and peptides, which can ... asparagine or rearrangement of aspartic acid residues ... does not depend on the monitoring of ...
Lipofectin Reagent is the reagent of choice for some cell lines; cells of endothelial derivation transfect well with Lipofectin Reagent....
Biology Products: